Annual ROE
-80.06%
-130.28%-259.42%
December 31, 2023
Summary
- As of February 8, 2025, INTS annual return on equity is -80.06%, with the most recent change of -130.28% (-259.42%) on December 31, 2023.
- During the last 3 years, INTS annual ROE has fallen by -467.05% (-120.69%).
- INTS annual ROE is now -120.69% below its all-time high of 386.99%, reached on December 1, 2020.
Performance
INTS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-209.74%
-73.13%-53.53%
September 30, 2024
Summary
- As of February 8, 2025, INTS quarterly return on equity is -209.74%, with the most recent change of -73.13% (-53.53%) on September 30, 2024.
- Over the past year, INTS quarterly ROE has stayed the same.
- INTS quarterly ROE is now -100.09% below its all-time high of 223.31 thousand%, reached on September 30, 2023.
Performance
INTS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
INTS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -259.4% | 0.0% |
| 3 y3 years | -120.7% | -564.9% |
| 5 y5 years | -135.4% | -564.9% |
INTS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -188.1% | at low | -100.1% | at low |
| 5 y | 5-year | -120.7% | at low | -100.1% | at low |
| alltime | all time | -120.7% | at low | -100.1% | at low |
Intensity Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -209.74%(+53.5%) |
| Jun 2024 | - | -136.61%(+33.4%) |
| Mar 2024 | - | -102.40%(-31.4%) |
| Dec 2023 | -80.06%(-259.4%) | -149.24%(-100.1%) |
| Sep 2023 | - | 223.31 K%(>+9900.0%) |
| Jun 2023 | - | 156.76%(+247.4%) |
| Mar 2023 | - | 45.12%(-23.9%) |
| Dec 2022 | 50.22% | 59.30%(-25.5%) |
| Sep 2022 | - | 79.58%(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 91.71%(-9.5%) |
| Mar 2022 | - | 101.38%(-2.3%) |
| Dec 2021 | 90.92%(-76.5%) | - |
| Dec 2021 | - | 103.73%(-41.1%) |
| Sep 2021 | - | 176.09%(-45.2%) |
| Jun 2021 | - | 321.14%(+60.7%) |
| Mar 2021 | - | 199.79%(+90.5%) |
| Dec 2020 | 386.99%(+70.9%) | 104.90% |
| Dec 2019 | 226.42% | - |
FAQ
- What is Intensity Therapeutics annual return on equity?
- What is the all time high annual ROE for Intensity Therapeutics?
- What is Intensity Therapeutics annual ROE year-on-year change?
- What is Intensity Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Intensity Therapeutics?
- What is Intensity Therapeutics quarterly ROE year-on-year change?
What is Intensity Therapeutics annual return on equity?
The current annual ROE of INTS is -80.06%
What is the all time high annual ROE for Intensity Therapeutics?
Intensity Therapeutics all-time high annual return on equity is 386.99%
What is Intensity Therapeutics annual ROE year-on-year change?
Over the past year, INTS annual return on equity has changed by -130.28% (-259.42%)
What is Intensity Therapeutics quarterly return on equity?
The current quarterly ROE of INTS is -209.74%
What is the all time high quarterly ROE for Intensity Therapeutics?
Intensity Therapeutics all-time high quarterly return on equity is 223.31 K%
What is Intensity Therapeutics quarterly ROE year-on-year change?
Over the past year, INTS quarterly return on equity has changed by 0.00% (0.00%)